Sanctuary Advisors LLC Purchases Shares of 19,329 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Sanctuary Advisors LLC purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 19,329 shares of the medical instruments supplier’s stock, valued at approximately $481,000.

Several other institutional investors and hedge funds have also recently modified their holdings of XRAY. PNC Financial Services Group Inc. raised its holdings in shares of DENTSPLY SIRONA by 11.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 67,988 shares of the medical instruments supplier’s stock valued at $2,420,000 after buying an additional 6,729 shares in the last quarter. Mather Group LLC. purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $72,000. Cannon Global Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $461,000. Oak Thistle LLC purchased a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $216,000. Finally, Principal Financial Group Inc. raised its holdings in shares of DENTSPLY SIRONA by 2.2% during the 1st quarter. Principal Financial Group Inc. now owns 1,425,571 shares of the medical instruments supplier’s stock valued at $47,315,000 after buying an additional 30,831 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $24.64 on Thursday. The firm has a market cap of $4.99 billion, a P/E ratio of -28.65, a P/E/G ratio of 1.17 and a beta of 1.00. DENTSPLY SIRONA Inc. has a fifty-two week low of $23.58 and a fifty-two week high of $37.60. The business’s 50 day moving average price is $25.27 and its 200-day moving average price is $26.88. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. DENTSPLY SIRONA’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.51 earnings per share. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a dividend of $0.16 per share. The ex-dividend date was Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.60%. DENTSPLY SIRONA’s dividend payout ratio is presently -74.42%.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on XRAY shares. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Needham & Company LLC reaffirmed a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI decreased their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.